Autus Asset Management’s Celgene Corp CELG Stock Holding History

Autus Asset Management’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-3,540	Closed	-$424K	–	166
2015 Q4	$424K	Buy	3,540 +180	+5%	+$20.8K	0.11%	121
2015 Q3	$363K	Sell	3,360 -640	-16%	-$79.4K	0.11%	101
2015 Q2	$463K	Hold	4,000	–	–	0.13%	97
2015 Q1	$461K	Hold	4,000	–	–	0.13%	96
2014 Q4	$447K	Hold	4,000	–	–	0.14%	86
2014 Q3	$379K	Sell	4,000 -50	-1%	-$4.51K	0.13%	89
2014 Q2	$348K	Sell	4,050 -4,000	-50%	-$304K	0.12%	90
2014 Q1	$562K	Hold	8,050	–	–	0.21%	76
2013 Q4	$680K	Hold	8,050	–	–	0.27%	64
2013 Q3	$620K	Buy	+8,050	New	+$564K	0.26%	68

Other funds holding CELG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Autus Asset Management's CELG Position: Q1 2016 in Review

Autus Asset Management sold out of Celgene Corp (CELG) in Q1 2016, closing a stake of 3,540 shares — an estimated $424K sold.

Autus Asset Management first reported a position in CELG in Q3 2013 and held it in 10 quarters. The position peaked at $680K in Q4 2013. 1,224 funds tracked by Wall St. Rank hold CELG as of Q1 2016.

Autus Asset Management reported no remaining Celgene Corp position as of Q1 2016 after selling out during the quarter.
Autus Asset Management sold 3,540 Celgene Corp shares in Q1 2016, an estimated $424K.
Autus Asset Management first reported a position in Celgene Corp in Q3 2013 and held it in 10 quarters.
Autus Asset Management's Celgene Corp position peaked at $680K in Q4 2013.
1,224 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2016.

Based on Autus Asset Management's 13F filing for Q1 2016, filed 10 May 2016.